Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis
Background/Aims: Atherosclerosis (AS) is one of the major leading causes of death globally, which is highly correlated with metabolic abnormalities. Resveratrol (REV) exerts beneficial effects on atherosclerosis. Our aim is to clarify the involvement of liver metabolic reprogramming and the atheropr...
Saved in:
Main Authors: | Ying Ma (Author), Dongliang Li (Author), Wenfeng Liu (Author), Xiaoxiao Liu (Author), Yingqi Xu (Author), Xinrui Zhong (Author), Fengnan Zhi (Author), Xueling Jia (Author), Yanan Jiang (Author), Yuhua Fan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Role and Potential Mechanism of Resveratrol in Atherosclerosis: TLR4/NF-κB/HIF-1α
by: Lin Guo, et al.
Published: (2023) -
Engineering lentivirus envelope VSV-G for liver targeted delivery of IDOL-shRNA to ameliorate hypercholesterolemia and atherosclerosis
by: Wei Wang, et al.
Published: (2024) -
Therapeutic effects of resveratrol and Omega-3 in mice atherosclerosis: focus on histopathological changes
by: Shamsi Sadat Mosavi, et al.
Published: (2023) -
Physcion Protects Against Ethanol-Induced Liver Injury by Reprogramming of Circadian Clock
by: Youli Yao, et al.
Published: (2020) -
Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
by: Aiwen Pi, et al.
Published: (2021)